Dr. Brian S. Planchard, MD

Dr. Planchard practices at Advanced Eye Care in Apopka, Florida.

Dr. Planchard's NPI, 1639377096, was assigned on July 6, 2007. Dr. Planchard graduated from Tulane School of Medicine in 2006. Dr. Planchard holds Florida license ME136778.

Dr. Planchard's primary practice is Advanced Eye Care, at 2257 E Semoran Blvd, Apopka, FL 32703 in Orange County. The practice phone is (407) 893-8200.

Dr. Planchard's primary practice is Advanced Eye Care in Apopka, Florida. Dmand AI also links Dr. Planchard to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Planchard practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Planchard's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Planchard is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Planchard's licenses on file in 5 states: Florida, Louisiana, Alabama, Texas and Indiana.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, eye infection or inflammation, eyelid inflammation and glaucoma among the conditions Dr. Planchard treats.

CMS data shows 915 Medicare services from Dr. Planchard across 12 procedure codes in 2024, for 348 Medicare patients. Medicare paid $66,597 for them.

CMS counts 348 Medicare patients who saw Dr. Planchard in 2024. The largest group is 75 to 84, with 149 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Planchard's median patient age at 71, with 57% women.

In 2024, Dr. Planchard wrote 453 Medicare Part D claims for 186 patients. 63% of them were for generic drugs. CMS names the drug for 348 of them, across 13 drugs with 11 or more claims each, at $30,764 in total drug cost. In 2023, CMS named 1,844 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Planchard for performance year 2024, reported as part of a group. Dr. Planchard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 55 procedures of cataract surgery by Dr. Planchard, more than 65% of the clinicians it reports for that procedure.

Dmand AI links 1 paper to Dr. Planchard. Dr. Planchard's most frequent co-author is Francis William Price, MD.

CMS Open Payments shows 91 general payments to Dr. Planchard from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $991.

Dr. Planchard graduated from Tulane School of Medicine in 2006.

Dr. Planchard is in network with 22 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.